LifeStance Health (LFST) Net Cash Flow (2020 - 2026)

LifeStance Health has disclosed Net Cash Flow across 7 years of filings, most recently posting -$53.8 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 166.1% year-over-year to -$53.8 million; the TTM figure through Mar 2026 stood at $60.5 million (down 28.77% YoY), while the FY2025 annual figure was $94.1 million, up 24.19% from the prior year.
• Net Cash Flow slipped to -$53.8 million in Q1 2026, from $44.7 million in the prior quarter.
• Over the last five years, Net Cash Flow for LFST reached as high as $54.6 million in Q2 2025 and fell as low as -$53.8 million in Q1 2026.
• The 5-year median for Net Cash Flow is $11.3 million (2023), against an average of $2.8 million.
• Annual changes were most pronounced in 2023 — Net Cash Flow sank 482.68% — and 2024, when it jumped 231.69%.
• A 5-year view of Net Cash Flow shows it stood at $18.3 million in 2022, then jumped by 98.08% to $36.2 million in 2023, then surged by 43.45% to $52.0 million in 2024, then declined by 13.89% to $44.7 million in 2025, then plunged by 220.35% to -$53.8 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$53.8 million, $44.7 million, and $15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.